Desmoid tumor future or investigational therapies: Difference between revisions
Jump to navigation
Jump to search
Sara Mohsin (talk | contribs) (→Source) |
Sara Mohsin (talk | contribs) (→Source) |
||
Line 19: | Line 19: | ||
==Source== | ==Source== | ||
*Information on current clinical trials is posted on the Internet at https://www.clinicaltrials.gov/ | *Information on current clinical trials is posted on the Internet at: | ||
*National Organization for Rare Disorders (NORD) https://rarediseases.org/rare-diseases/desmoid-tumor/ | **https://www.clinicaltrials.gov/ | ||
**National Organization for Rare Disorders (NORD) https://rarediseases.org/rare-diseases/desmoid-tumor/ | |||
==Reference== | ==Reference== |
Revision as of 18:34, 4 March 2019
Desmoid tumor Microchapters |
Diagnosis |
---|
Treatment |
Case Studies |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Associate Editor(s)-in-Chief: Sara Mohsin, M.D.[2]
Overview
Future or Investigational therapies
- Following investigational therapies might prove fruitful in future for treatment of desmoid tumors:
Angiogenesis inhibitors
- Newer substances that may be able to prevent the growth of tumors by blocking the formation of new blood vessels that feed the tumors are being currently investigated
Chemotherapy agents
- Researchers are also testing several chemotherapy drugs, or combination of drugs, that could prove to be most effective in treating desmoid tumors to avoid radical management via surgery
Mutations in the gene for beta-catenin
- These mutations have been found to commonly occur in desmoid tumor
- Mutation analysis may soon be used to predict the risk of recurrence and to aid in the design of individual therapies
Source
- Information on current clinical trials is posted on the Internet at:
- https://www.clinicaltrials.gov/
- National Organization for Rare Disorders (NORD) https://rarediseases.org/rare-diseases/desmoid-tumor/